Optiray (Ioversol)

Ioversol, the active ingredient in Optiray, is an iodinated contrast media presented as a solution for injection for intraarterial and intravenous use. It enhances radiographic imaging of blood vessels and organs in diagnostic procedures.

GNH USA supplies Optiray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Optiray (ioversol) is used as an iodinated contrast agent in diagnostic imaging procedures.

- Angiography: provides high‑contrast visualization of arterial and venous structures. - Computed tomography (CT) imaging: enhances tissue differentiation and lesion detection. - Urography: improves delineation of the urinary tract and renal collecting system. - Cerebral angiography: facilitates detailed imaging of cerebral vasculature. - Cardiac catheterization: aids visualization of coronary arteries and cardiac chambers.

Adverse reactions may occur following administration of Optiray.

Common Side Effects: - Warm sensation or flushing at the injection site - Metallic taste in the mouth - Nausea or mild vomiting - Headache - Transient urticaria or skin redness - Mild dizziness

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Acute renal impairment or contrast‑induced nephropathy - Hypotension or cardiovascular collapse - Cardiac arrhythmias - Seizures or neurologic disturbances - Pulmonary edema or respiratory distress

Prior to using Optiray, clinicians should consider several safety measures.

- Renal function assessment: evaluate serum creatinine and eGFR before injection. - Allergy history: screen for prior reactions to iodinated contrast or iodine‑containing substances. - Dose minimisation: use the lowest volume required for adequate imaging. - Vital sign monitoring: observe blood pressure and heart rate during and after administration. - Contra‑indication review: avoid in patients with known severe iodine hypersensitivity. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Optiray may interact with other agents that affect renal function or allergic response.

Major Interactions (Avoid): - Concurrent iodinated contrast agents: cumulative iodine load can increase toxicity. - Nephrotoxic drugs (e.g., aminoglycosides, high‑dose NSAIDs): heighten risk of renal injury. - High‑dose corticosteroids: may mask early signs of an allergic reaction.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may alter hemodynamic response during contrast injection. - Diuretics: can affect renal clearance of iodine. - ACE inhibitors or ARBs: may increase susceptibility to contrast‑induced nephropathy. - Anticoagulants: monitor bleeding risk if invasive imaging is performed. - Thyroid medications: excess iodine may interfere with thyroid hormone regulation.